Literature DB >> 8354314

Apolipoprotein E phenotypes and plasma lipids in diabetic children and adolescents.

M K Salo1, R Rantanen, T Huupponen, T Lehtimäki, H Jokela.   

Abstract

Apolipoprotein E (apoE) polymorphism is a genetic determinant of serum lipoprotein levels and coronary heart disease risk. ApoE appears in three major isoforms E2, E3 and E4, coded by corresponding alleles epsilon 2, epsilon 3 and epsilon 4. These give six different phenotypes. Patients with insulin dependent diabetes (IDDM) have been reported to have increased incidence of E2/2 homozygosity. We studied the frequencies of apoE phenotypes and their association with plasma lipids in 201 diabetic children, aged 2-17 years, and in 216 healthy controls with the same age range. Phenotyping was performed directly from plasma by iso-electric focusing and immunoblotting. Plasma total and high density lipoprotein (HDL) cholesterol (C) and triglycerides were determined by routine laboratory methods. Apolipoprotein A1 (apoA1) and B (apoB) were measured by turbidometry. There were no differences in apoE phenotype or allele distributions between the diabetic and control subjects. The frequencies of epsilon 2, epsilon 3, and epsilon 4 in the diabetic and control children were 0.08 versus 0.07, 0.73 versus 0.72 and 0.19 versus 0.21. The difference in apoE2/2 frequencies (2.0 in diabetic and 0.5% in normal children) was not statistically significant. In the diabetic children, there was a distinct relation between apoE phenotype and plasma lipids; presence of apoE2 was associated with the lowest and that of apoE4 with the highest concentrations of total and low density lipoprotein (LDL) C, and apoB. Ratios of HDL-C/LDL-C and apoA1/apoB showed on opposite trend. The influence of apoE polymorphism on plasma lipids was less clear in the controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354314     DOI: 10.1007/bf01954081

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  19 in total

1.  Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.

Authors:  J de Graaf; H L Hak-Lemmers; M P Hectors; P N Demacker; J C Hendriks; A F Stalenhoef
Journal:  Arterioscler Thromb       Date:  1991 Mar-Apr

2.  Apolipoprotein E polymorphism and lipoproteins in insulin-treated diabetes mellitus.

Authors:  P H Winocour; L Tetlow; P N Durrington; M Ishola; V Hillier; D C Anderson
Journal:  Atherosclerosis       Date:  1989-02       Impact factor: 5.162

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000.

Authors:  C Izzo; F Grillo; E Murador
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

5.  Apolipoprotein E phenotypes in Finnish youths: a cross-sectional and 6-year follow-up study.

Authors:  T Lehtimäki; T Moilanen; J Viikari; H K Akerblom; C Ehnholm; T Rönnemaa; J Marniemi; G Dahlen; T Nikkari
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

Review 6.  Apolipoprotein E polymorphism in health and disease.

Authors:  G Utermann
Journal:  Am Heart J       Date:  1987-02       Impact factor: 4.749

Review 7.  Plasma lipoproteins: apolipoprotein structure and function.

Authors:  R W Mahley; T L Innerarity; S C Rall; K H Weisgraber
Journal:  J Lipid Res       Date:  1984-12-01       Impact factor: 5.922

8.  Low-density lipoprotein subclass patterns and risk of myocardial infarction.

Authors:  M A Austin; J L Breslow; C H Hennekens; J E Buring; W C Willett; R M Krauss
Journal:  JAMA       Date:  1988-10-07       Impact factor: 56.272

9.  Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation.

Authors:  C F Sing; J Davignon
Journal:  Am J Hum Genet       Date:  1985-03       Impact factor: 11.025

10.  Apolipoprotein E-binding proteins isolated from dog and human liver.

Authors:  U Beisiegel; W Weber; J R Havinga; G Ihrke; D Y Hui; M E Wernette-Hammond; C W Turck; T L Innerarity; R W Mahley
Journal:  Arteriosclerosis       Date:  1988 May-Jun
View more
  4 in total

1.  LDL composition in E2/2 subjects and LDL distribution by Apo E genotype in type 1 diabetes.

Authors:  Susan J Murdoch; Andrew P Boright; Andrew D Paterson; Bernard Zinman; Michael Steffes; Patricia Cleary; Karen Edwards; Santica S Marcovina; Jonathan Q Purnell; John D Brunzell
Journal:  Atherosclerosis       Date:  2006-06-05       Impact factor: 5.162

2.  Apolipoprotein E phenotypes and cardiovascular responses to experimentally induced mental stress in adolescent boys.

Authors:  N Ravaja; K Räikkönen; H Lyytinen; T Lehtimäki; L Keltikangas-Järvinen
Journal:  J Behav Med       Date:  1997-12

3.  Does low birth weight affect the presence of cardiometabolic risk factors in overweight and obese children?

Authors:  Caroline Ponzio; Zaira Palomino; Rosana Fiorini Puccini; Maria Wany L Strufaldi; Maria C P Franco
Journal:  Eur J Pediatr       Date:  2013-08-03       Impact factor: 3.183

4.  Analysis of apolipoprotein E genetic polymorphism in a large ethnic Hakka population in southern China.

Authors:  Zhixiong Zhong; Heming Wu; Hesen Wu; Pingsen Zhao
Journal:  Genet Mol Biol       Date:  2018-11-29       Impact factor: 1.771

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.